1.
Moreau P, Coiteux V, Hulin C, Leleu X, van de Velde H, Acharya M, Harousseau J-L. Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma. Haematologica [Internet]. 2008Dec.2 [cited 2026Nov.9];93(12):1908-11. Available from: https://haematologica.org/article/view/5118